However, in the validation set, only the association between the IGF1 rs5742714 polymorphism and decreased risk of RCC was verified (OR = 0.79, 95% CI = 0.63–0.98, GC/CC vs. GG). This evidence concerns the gene IGF1 and renal cell adenocarcinoma.